Systemic effects on bone healing of a new hyaluronic acid-like bacterial exopolysaccharide

Calcified Tissue International

Volumn 73, Issue 3, 2003, Pages 232-236

  Zanchetta, P ^a   Lagarde, N ^a   Guezennec, J ^b  

^a CHU MORVAN   (France)

^b IFREMER   (France)

Author keywords

Bone healing; Calvaria; Critical size defects; Exopolysaccharide; HE 800; Rats; Systemic

Indexed keywords

BACTERIAL POLYSACCHARIDE; HYALURONIC ACID DERIVATIVE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BONE GROWTH; BONE REGENERATION; BONE STRUCTURE; CONTROLLED STUDY; DEEP SEA; EVALUATION; FRACTURE HEALING; HISTOPATHOLOGY; HYDROTHERMAL VENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKULL; SKULL RADIOGRAPHY; TECHNIQUE; TRABECULAR BONE; VIBRIO; VIBRIO DIABOLICUS;

ANIMALS; BONE REGENERATION; BONE SUBSTITUTES; MALE; OSSEOINTEGRATION; PARIETAL BONE; POLYSACCHARIDES, BACTERIAL; RATS; RATS, WISTAR; VIBRIO;

EID: 0141634238     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-002-2081-7     Document Type: Article

References (43)

1. Marden LJ, Hollinger JO, Chaudhari A (1994) Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats. J Biomed Mater Res 27:127-138
2. Meddahi A, Blanquaert F, Saffar JL, Colombier ML (1994) New approaches to tissues regeneration and repair. Path Res Pract 190:923-927
3. Rougeaux H, Kervarec N, Pichon R, Guezennec J (1999) Structure of the exopolysaccharide of Vibrio diabolicus isolated from a deep-sea hydrothermal vent. Carbohydr Res 412:40-45
4. Bosch C, Melsen B, Vargervik K (1995) Guided bone regeneration in calvaria bone defects using polytetrafluoroethylene membrane. Cleft Palate Craniofac J 41:401-407
5. Bosch C, Melsen B, Gibbons R (1996) Human recombinant transforming growth factor β1 in healing of calvaria bone defects. J Craniofac Surg 7:390-400
6. Cuevas PD, De Paz V, Cuevas B (1997) Osteopromotion for cranioplasty: an experimental study in rats using acidic fibroblast growth factor. Surg Neurol 47:242-246
7. Zanchetta P, Guezennec J (2001) Surface thermodynamics of osteoblasts: relation between hydrophobicity and bone active biomaterials. J Colloid Surfaces B Biointerfaces 22:391-397
8. Zanchetta P, Lagarde N, Guezennec J (2002) A new bone healing material: a heparin-chondroitin-hyaluronic-like bacterial exopolysaccharide. Calcif Tissue Int:(in press)
9. Meddahi A, Caruelle JP, Gold L, Rosso Y (1996) New concepts in tissue repair: skin as an example. Diabetes Metab 22:274-278
10. Isobe M, Yamazaki Y, Oida SI (1996) Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer. J Biomed Mater Res 41:442-438
11. Naaman N, Ouhayoun JP (1998) Bone formation with disk or particles of natural coral skeleton plus polylactin 910 Mesh: histologic evaluation in rat calvaria. Int J Oral Maxillofac Implants 13:121-120
12. Papay FA, Morales L, Ahmed OF (1996) Comparison of ossification of demineralized bone, hydroxyapatite, gel, and bone wax in cranial defect repair. J Craniofac Surg 7:347-351
13. Tardieu M, Gamby C, Avramoglou T (1992) Derivated dextrans mimics heparin as stabilizers, potentiators, and protector of acidic or basic FGF. J Cell Physiol 210:194-203
14. Trecant M, Delécrin J, Royer J (1995) Mechanical changes in macroporous calcium phosphate ceramics after implantation in bone. Clin Mater 21:240-242
15. Aviezier D, Levy E, Safran M (1994) Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem 269:114-121
16. Blanquaert F, Saffar JL, Colombier ML (1995) Heparin-like molecules induce the repair of skull defects. Bone 17:499-506
17. Blanquaert F, Barritault D, Caruelle JP (1999) Effects of heparin-like polymers associated with growth factors on osteoblast proliferation and phenorype expression. J Biomed Mater Res 44:63-72
18. Sieron AL, Louneva N, Fertala A (2002) Site-specific interaction of bone morphogenetic protein 2 with procollagen II. Cytokine 18:214-221
19. Meddahi A, Alexakis C, Papy D, Caruelle JP, Barritault D (2001) Heparin-like polymer improved healing of gastric and colic alteration. J Biomed Mater Res 60:497-501
20. Barnes GL, Kostenuik PJ, Gerstenfeld LC (1999) Growth factor regulation of fracture repair. J Bone Miner Res 14:1805-1821
21. Frost HM (1989) The biology of fracture healing. Clin Orthop 248:273-383
22. Hill PA, Reynolds JJ, Meickle MC (1995) Osteoblasts mediate insulin-like growth factor-I and II stimulation of osteoclast formation and function. Endocrinology 136:124-140
23. Esford L, Maiti A, Bader S (1998) Analysis of CD 44 interactions with hyaluronan in murine L cell fibroblasts deficient in GAG synthesis: a role of chondroitin sulfate. J Cell Sci 111:1021-1038
24. Jerdan J, Michels R, Glaser B (1991) Extracellular matrix of newly forming vessels, an immunohistochemical study. Microvasc Res 42:255-265
25. Lipscombe R, Nakhoul N, Sanderson C (1998) Interleukin-5 binds heparin/heparan sulfate. A model for an interaction with extracellular matrix. J Leukoc Biol 63:342-350
26. Marchetti D, Liu S, Spohn WC, Carson D (1997) Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cells surface and extracellular matrix heparan sulfate. J Biol Chem 272:21891-21897
27. Anderson I (2001) The properties of hyaluronan and its role in wound healing. Professional Nurse 17:241-235
28. Jacob A, Faddio B, Chole R (2002) Merogel hyaluronic acid sinonasal implants: osteogenic applications. Laryngoscope 112:37-42
29. Lisignoli G, Fini M, Giavaresi G, Aldini N, Toneguzzi S, Facchini A (2002) Osteogenesis of large segmental radius defects enhanced by βTGF activated bone marrow stromal cells grown on non-woven hyaluronic acid-based polymer scaffold. Biomaterials 23:1043-1051
30. Loaëc M, Olier R, Guezennec J (1997) Uptake of lead, cadmium and zinc by a novel bacterial exopolysaccharide. Wat Res 40:1171-1179
31. Sasaki T, Watanabe C (1995) Stimulation of osteoinduction in bone wound healing by hyaluronic acid. Bone 16:9-15
32. Bandari M, Hirsh J, Weitz J, Young E, Vennec T, Slaufghnessy S (1998) The effects of standard and low molecular weight heparin on bone nodule formation in vitro. Thromb Haemost 80:413-417
33. Hioki I, Nishikawa M, Osada K, Shimono T, Shimpo H, Tanaka K, Suzuki Y, Shiku H, Ikida Y, Yodo I (1998) A heparin-coated circuit maintains platelet aggregability in response to shear stress in an in vitro model of cardio-pulmonary bypass. Thromb Haemost 80:437-442
34. Saliba M, Heparin in the treatment of burns, a review. Burns 27349358
35. Brunel G, Piantoni P, Elharar F (1996) Regeneration of rat calvaria defects using a bioresorbable membrane technique: influencc of collagen cross-linking. J Periodontol 67:1342-1348
36. Muzzarelli R, Mattidi-Belmonte M, Pugnanoli A, Biagini G (1999) Biochemistry, histology and clinical use of chitin and chitosans in wound healing. EXS 87:251-264
37. Logeart D, Letourneur D, Jozefonvicz J (1996) Collagen synthesis by vascular smooth cells in the presence of antiproliferative polysaccharides. J Biomed Mater Res 39:501-508
38. Logeart D, Prigent-Richard S, Jozefonvicz J, Letourneur D (1997) Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth cell proliferation. Comparison with heparin for antiproliferative activity, binding and internalization. Euro J Cell Biol 74:376-384
39. Desmoulières A, Darby I, Costa AMA (1997) Extracellular matrix deposition, lysil oxidase expression and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat, Lab Invest 76:765-778
40. Schmitz JP, Jeffrey O, Hollinger O (1986) The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop 205:389-398
41. Schmitz JP, Schwartz Z, Jeffrey O, Hollinger O. (1990) Characterization of calvarial non-union defects. Acta Anat 138:185-192
42. Zanchetta P, Berthou F, Guezennec J, Mittelmann M (2000) Tension d' adhésion et adhésion bactérienne: rôle des exopolysaccharides. J Biomater Dent 14:63-76
43. Kainulainen V, Wang H, Schick C (1998) Syndecans, heparan sulfates proteoglycans, intain the proteolytic balance of acute wound fluids. J Biol Chem 273:11563-11569